These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Estradiol induction of retinoic acid receptors in human breast cancer cells. Roman SD, Ormandy CJ, Manning DL, Blamey RW, Nicholson RI, Sutherland RL, Clarke CL. Cancer Res; 1993 Dec 15; 53(24):5940-5. PubMed ID: 8261407 [Abstract] [Full Text] [Related]
4. Emergence of MCF-7 cells overexpressing a transfected epidermal growth factor receptor (EGFR) under estrogen-depleted conditions: evidence for a role of EGFR in breast cancer growth and progression. Miller DL, el-Ashry D, Cheville AL, Liu Y, McLeskey SW, Kern FG. Cell Growth Differ; 1994 Dec 15; 5(12):1263-74. PubMed ID: 7696175 [Abstract] [Full Text] [Related]
6. Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha. Kinoshita Y, Chen S. Cancer Res; 2003 Jul 01; 63(13):3546-55. PubMed ID: 12839940 [Abstract] [Full Text] [Related]
7. Altered gene expression in drug-resistant human breast cancer cells. Wosikowski K, Schuurhuis D, Kops GJ, Saceda M, Bates SE. Clin Cancer Res; 1997 Dec 01; 3(12 Pt 1):2405-14. PubMed ID: 9815641 [Abstract] [Full Text] [Related]
8. Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors. Creighton CJ, Hilger AM, Murthy S, Rae JM, Chinnaiyan AM, El-Ashry D. Cancer Res; 2006 Apr 01; 66(7):3903-11. PubMed ID: 16585219 [Abstract] [Full Text] [Related]
10. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta. Buteau-Lozano H, Ancelin M, Lardeux B, Milanini J, Perrot-Applanat M. Cancer Res; 2002 Sep 01; 62(17):4977-84. PubMed ID: 12208749 [Abstract] [Full Text] [Related]
16. Molecular mechanisms of loss of beta 2-microglobulin expression in drug-resistant breast cancer sublines and its involvement in drug resistance. Ogretmen B, McCauley MD, Safa AR. Biochemistry; 1998 Aug 18; 37(33):11679-91. PubMed ID: 9709006 [Abstract] [Full Text] [Related]
19. Expression of a constitutively active estrogen receptor variant in the estrogen receptor-negative BT-20 human breast cancer cell line. Castles CG, Fuqua SA, Klotz DM, Hill SM. Cancer Res; 1993 Dec 15; 53(24):5934-9. PubMed ID: 8261406 [Abstract] [Full Text] [Related]
20. 17beta-hydroxysteroid dehydrogenase 14 affects estradiol levels in breast cancer cells and is a prognostic marker in estrogen receptor-positive breast cancer. Jansson AK, Gunnarsson C, Cohen M, Sivik T, Stål O. Cancer Res; 2006 Dec 01; 66(23):11471-7. PubMed ID: 17145895 [Abstract] [Full Text] [Related] Page: [Next] [New Search]